Safety creatinine clearance level for platinum chemotherapy in lung cancer patients

Oncology Letters

Volumn 3, Issue 2, 2012, Pages 311-314

  Ohara, Gen ^a,b   Miyazaki, Kunihiko ^b   Kurishima, Koichi ^b   Kagohashi, Katsunori ^a   Ishikawa, Hiroichi ^c   Satoh, Hiroaki ^a   Hizawa, Nobuyuki ^b  

^a NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Tsukuba Medical Center   (Japan)

Author keywords

Creatinine clearance; Elderly; Lung cancer; Renal function

Indexed keywords

CARBOPLATIN; CHROMIUM CHLORIDE; CISPLATIN; CREATININE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG SAFETY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY; SIDE EFFECT;

EID: 84855252115     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.486     Document Type: Article

References (21)

1. Satoh H, Kurishima K, Nakamura R, et al: Lung cancer in patients aged 80 years and over. Lung Cancer 65: 112-118, 2009.
2. Vamvakas L, Saloustros E, Karampeazis A and Georgoulias V: Advanced non-small-cell lung cancer in the elderly. Clin Lung Cancer 10: 158-167, 2009.
3. Lang K, Marciniak MD, Faries D, et al: Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States. Lung Cancer 63: 264-270, 2009.
4. Sanborn RE: Cisplatin versus carboplatin in NSCLC: is there one 'best' answer? Curr Treat Options Oncol 9: 326-342, 2008.
5. Thyss A, Saudes L, Otto J, Creisson A, Gaspard MH, Dassonville O, et al: Renal tolerance of cisplatin in patients more than 80 years old. J Clin Oncol 12: 2121-2125, 1994.
6. Lababede O, Meziane M and Rice T: Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams. Chest 139: 183-189, 2011.
7. Cockcroft DW and Gault MH: Prediction of creatinine clearance from plasma creatinine. Nephron 16: 31-41, 1976.
8. Horio M and Orita Y: Comparison of Jaffē rate assay and enzymatic method for the measurement of creatinine clearance. Jap J Nephrol 38: 296-299, 1996.
9. Sweileh WM, Sawalha AF, Zyoud SH, Al-Jabi1 SW and Shraim NY: Prevalence of reduced renal function among diabetic hypertensive patients. Int J Physiol Pathophysiol Pharmacol 1: 41-47, 2009.
10. Wu MC, Lee WJ, Tschen SM, Lin SY, Lee IT, Jeng CY, et al: Predictors of mortality in hospitalized diabetic patients: A 7-year prospective study. Diabetes Res Clin Pract 80: 449-454, 2008.
11. Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Paolo Elia P, et al: Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25: 206-211, 2004.
12. Quoix E: Carboplatin-based Doublet Effective for Elderly Patients with NSCLC. Plenary Session at ASCO's 2010 Annual Meeting (Abstract 2).
13. Kaplan C, Pasternack B, Shah H and Gallo G: Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80: 227-234, 1975.
14. Tauchi H, Tsuboi K and Sato K: Histology and experimental pathology of senile atrophy of the kidney. Nagoya Med J 4: 71-97, 1958.
15. Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: 167-184, 1990.
16. Beck LH: Changes in renal function with aging. Clinics in Geriatric Medicine 11: 199-209, 1998.
17. Herig PJ and Carlson RE: Plasma creatinine and renal function in the elderly. JAMA 248: 31, 1982.
18. Millward MJ, Webster LK, Toner GC, et al: Carboplatin dosing based on measurement of renal function - experience at the Peter MacCallum Cancer Institute. Aust N Z J Med 26: 372-379, 1996.
19. Peters AM: Quantification of renal haemodynamics with radionucleotides. Eur J Nucl Med 18: 274-286, 1991.
20. Fawdry RM, Gruenewald SM, Collins LT and Roberts AJ: Comparative assessment of the techniques for estimation of glomerular filtration rate with 99mTc-DTPA. Eur J Nucl Med 11: 7-12, 1985.
21. Rehling M, Møller ML, Thamdrup B, Lund JO and Trap-Jensen J: Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci (Lond) 66: 613-619, 1984.